{"cdcTestId":"2013-0212","testcaseName":"Dose 2 to dose 3 interval 8 wks-5 days in adolescent with two Recombivax not meeting rules for two dose adoles. 4th dose needed","vaccineGroup":"HepB","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval ","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2009-01-19T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-05-19T00:00:00","vaccineName":"RECOMBIVAX-ADULT","cvx":"43","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-19T00:00:00","vaccineName":"RECOMBIVAX-ADULT","cvx":"43","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-09T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"4","earliestDate":"2022-10-14T00:00:00","recommendedDate":"2022-10-14T00:00:00","pastDueDate":"2022-10-14T00:00:00"},"doses":[{"dateAdministered":"2022-05-19T00:00:00","vaccineName":"RECOMBIVAX-ADULT","cvx":"43","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-19T00:00:00","vaccineName":"RECOMBIVAX-ADULT","cvx":"43","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-10-09T00:00:00","vaccineName":"RECOMBIVAX-PEDS","cvx":"08","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2020-06-18T08:03:52.749","generalDescription":"This test case describes when dose #3 of the Hep B Recomibivax vaccine is administered at an interval of 8 weeks - 5 days from dose #2 to an adolescent child, that the dose is valid, but a fourth dose is required.","changedInVersion":"4.2","reasonForChange":"V4.2: Updated Forecast Test Type to \u0022Recommended base on interval\u0022\nV4.1: Changed forecast to reflect new 4-dose guidance from CEB.\nV3.1: Changed dose 3 from not valid to valid due to recent clarifications.  Also changed test case name to reflect a 4th dose is required."}